The END Fund Chief Executive Officer Ellen Agler says that because of the coronavirus pandemic, her organization has put a pause on all mass drug distribution campaigns designed to prevent neglected tropical diseases.
In an interview with Devex President and Editor-in-Chief Raj Kumar, Agler described how The END Fund, a major NTD funder, recently received a proposal in one country to shift from a campaign approach to disease prevention to a door-to-door approach — an effort that would cost 20% more.
For more on the future of NTD eradication in the wake of the COVID-19 pandemic, tune in to the complete interview.
More interviews with humanitarian leaders on COVID-19. Watch:
• Peter Sands' 'nightmare' coronavirus scenario
• Rockefeller Foundation’s pandemic chief calls for ‘herd awareness’
• UNAIDS director warns of 'colliding epidemics'
• InterAction's CEO on the pandemic's financial impact on NGOs
Visit our dedicated COVID-19 page for news, job opportunities, and funding insights.
About the author
Raj Kumarraj_devex
Raj Kumar is the President and Editor-in-Chief at Devex, the media platform for the global development community. He is a media leader and former humanitarian council chair for the World Economic Forum and a member of the Council on Foreign Relations. His work has led him to more than 50 countries, where he has had the honor to meet many of the aid workers and development professionals who make up the Devex community. He is the author of the book "The Business of Changing the World," a go-to primer on the ideas, people, and technology disrupting the aid industry.